Axovant Sciences, Ltd. IPO Research Information

Axovant Sciences, Ltd. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Axovant Sciences, Ltd., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Axovant Sciences, Ltd.	AXON - NYSE	$13.00-$15.00	$15.00	$20.93	21 million	6/11/2015
Underwriter(s): Jefferies, Evercore ISI, RBC Capital Markets
Co-Manager(s): JMP Securities, Baird
Industry: Health Care
Filing(s): Filed 2015-05-11 Terms Added 2015-06-01

Axovant Sciences, Ltd. Quote & Chart - Click for current quote - AXON

About Axovant Sciences, Ltd. (adapted from Axovant Sciences, Ltd. prospectus):
They are a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "AXON" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.